REHOVOT, Israel and NEW BRUNSWICK, N.J., May 1 /PRNewswire-FirstCall/
-- Rosetta Genomics, Ltd. (Nasdaq: ROSG) announced that the company will
report first quarter 2007 financial results on Tuesday, May 8, 2007, after
U.S. financial markets close. Following the announcement, senior management
will host a conference call and webcast at 4:30 p.m. Eastern Time to
discuss financial results and corporate highlights.
To access the live conference on May 8 at 4:30 p.m. Eastern Time via
phone, please dial (866)-409-1557 from the United States and Canada or
1-(913)-312-1237 internationally. The conference passcode is 3026948.
Please dial in approximately fifteen minutes prior to the start of the
call. A telephone replay will be available beginning approximately one hour
after the call through May 15 and may be accessed by dialing (888)-203-1112
from the United States and Canada or 1-(719)-457-0820 internationally. The
replay passcode is 3026948.
To access the live and subsequently archived webcast of the conference
call, go to the Investor Relations section of the Company's website at
http://www.rosettagenomics.com. Please connect to the web site at least 15
minutes prior to the call to allow for any software download that may be
About Rosetta Genomics
Rosetta Genomics (Nasdaq: ROSG) is a leader in the development of
microRNA-based diagnostics and therapeutics. The company's integrative
research platform combining bioinformatics and state-of-the-art laboratory
processes has led to the discovery of hundreds of biologically validated
novel human microRNAs. Building on its strong IP position and strategic
alliances with leading biotechnology companies, Rosetta Genomics is working
to develop a full range of diagnostic and therapeutic products based on
microRNAs. The company's primary focus is in the development of
microRNA-based products to diagnose and treat different forms of cancer and
Media and Investors
Ron Kamienchick, 972-8-948-4785
SOURCE Rosetta Genomics, Ltd.